Gaits F, Fourcade O, Le Balle F, Gueguen G, Gaigé B, Gassama-Diagne A, Fauvel J, Salles J P, Mauco G, Simon M F, Chap H
Institut Fédératif de Recherche en Immunologie Cellulaire et Moléculaire, Université Paul Sabatier, INSERM Unité 326, Phospholipides Membranaires, Signalisation Cellulaire et Lipoprotéines, Hôpital Purpan, Toulouse, France.
FEBS Lett. 1997 Jun 23;410(1):54-8. doi: 10.1016/s0014-5793(97)00411-0.
From very recent studies, including molecular cloning of cDNA coding for membrane receptors, lysophosphatidic acid (LPA) reached the status of a novel phospholipid mediator with various biological activities. Another strong argument supporting this view was the discovery that LPA is secreted from activated platelets, resulting in its appearance in serum upon blood coagulation. The metabolic pathways as well as the enzymes responsible for LPA production are poorly characterized. However, a survey of literature data indicates some interesting issues which might be used as the basis for further molecular characterization of phospholipases A able to degrade phosphatidic acid.
从最近的研究,包括对编码膜受体的cDNA进行分子克隆来看,溶血磷脂酸(LPA)已成为具有多种生物活性的新型磷脂介质。支持这一观点的另一个有力证据是发现LPA由活化的血小板分泌,导致其在血液凝固时出现在血清中。LPA产生的代谢途径以及负责其产生的酶的特征尚不明确。然而,对文献数据的调查表明了一些有趣的问题,这些问题可能作为进一步对能够降解磷脂酸的磷脂酶A进行分子特征研究的基础。